Roche’s Vabysmo improved vision in underrepresented populations with DME in a first-of-its-kind study
Efficacy and safety from this phase IV study were consistent with data from the Vabysmo phase III DME studies
Efficacy and safety from this phase IV study were consistent with data from the Vabysmo phase III DME studies
These gummies are specially formulated for both kids and adults to nourish the eyes and promote optimal vision development
Vabysmo PFS is the first and only syringe prefilled with an FDA-approved bispecific antibody to treat retinal conditions that can cause blindness
Dr Madhu will oversee Apollo's hospital business and will focus on continuing to deliver the world's best clinical outcomes
The company is confident of addressing all the observations within the stipulated time
The company achieved 100% capacity utilisation in the division. These accomplishments stand as a testament to the company's dedication and vision
As Caeregen’s CDMO partner for CTR-107, Wacker Biotech will produce drug substance at its site in Halle, Germany, and complete clinical trial drug product production at its site in Amsterdam, the Netherlands
This is the second US FDA GMP inspection of this facility within one year
Concept Medical’s manufacturing arm has reduced its carbon footprint via in-house efficiency improvement programmes & green infrastructure
“One Earth, One Health” vision can become a reality only with active global collaboration where countries don’t think of only themselves, but of collective global outcomes
Subscribe To Our Newsletter & Stay Updated